- Review restrictions
- Approve language
- Protect follow-up
Start with current policy
Google's personalized-advertising restrictions include health-related interests. Review the specific campaign and audience approach rather than assuming ordinary remarketing is appropriate. Clinicians should approve service descriptions and claims.
Use a suitable destination
Explain the approved first-contact process and avoid collecting detailed clinical information in advertising tools. Dappr can coordinate campaigns with the practice's reviewers, reporting appropriate inquiries separately from clicks. No advertisement should promise recovery, diagnosis or guaranteed appointment availability.
Choose an available service and a clear first step
Imagine a fictional therapy practice considering a campaign for an introductory consultation process it has already approved. The campaign should explain that process and the actual service rather than promise recovery or assume the viewer has a diagnosis. This example is a planning scenario, not a patient story, Dappr case study or forecast of appointment demand.
Confirm that the practice can accept the inquiries being invited. Identify the clinician reviewer, intake owner, appropriate geographic scope and any restrictions on the advertised service. A campaign that continues after availability changes can mislead prospective clients even if the original ad was accurate. Establish how staff communicate a pause or change before the campaign is activated.
Review the specific campaign against current policy
Google personalized-advertising policy includes health among sensitive interest categories and restricts advertiser-curated audiences for those categories. Do not assume that ordinary remarketing or an uploaded contact list is appropriate for therapy advertising. The actual offer, audience settings and campaign type need review together with the destination.
Keep platform policy review distinct from clinical and legal review. An ad being accepted does not establish that every data flow or professional statement is appropriate, while a clinically accurate statement may still require a different advertising approach. Document unresolved questions and the person responsible for resolving them. A proposal should not promise an audience feature that the actual account or service cannot use.
Make the search message specific without diagnosing the reader
Use approved service language and a practical invitation to learn about the consultation process. Avoid statements that claim to know what a person is experiencing or present an individual outcome as predictable. The ad should identify the practice accurately and lead to information that supports an informed next step.
For the fictional practice, the message could focus on how to request a conversation about service fit. The destination then explains who provides the service and how the request is reviewed. Do not use exaggerated urgency to force a decision or imply that a limited advertising offer determines access to necessary care. Have the clinician review the full ad and page combination, including short headlines.
Prepare a destination with an approved contact boundary
The landing page needs current professional information, actual appointment arrangements and clear first-contact instructions. A visitor should understand whether they are asking a question, requesting a consultation or using a separate approved scheduling system. The button and confirmation wording should match the real action.
Keep detailed clinical history outside a general advertising form. The practice should approve fields, routing, access and any external tools used in the journey. A campaign page is not automatically suitable for sensitive information because it belongs to a healthcare business. Review the complete arrangement, including what notifications contain and what is sent to measurement services.
Decide what measurement is appropriate before implementation
A useful measurement plan begins with the decision it must support and the information it would collect. Do not add tags or enhanced data sharing merely because those options are recommended in a general advertising setup. Inspect the actual event payloads, page addresses and form behavior with the practice responsible reviewers.
HHS guidance discusses marketing uses of protected health information and online tracking by regulated entities, with important scope qualifications. Apply qualified review to the specific circumstances rather than treating a generic consent banner as a universal solution. The report can state what was observed and what remains unknown without claiming complete tracking of every prospective client journey.
Separate advertising actions from clinical outcomes
A click, a contact request and a confirmed appointment are different actions. A later clinical outcome is different again and should not be inferred from advertising data. Use reporting labels that match what the approved implementation can actually observe. If only a page interaction is measured, call it that rather than presenting it as a new client.
Staff can provide appropriately limited feedback about whether the campaign is generating requests within the advertised scope. That feedback should not require sharing diagnoses or treatment details with the marketing team. Review aggregate operational patterns and unresolved questions. A low reported cost per action is not evidence that the campaign improved health or delivered suitable care.
Set a controlled review and change process
Agree on authorized spend, management responsibilities and the evidence used at review meetings. A proposed change to copy, audience settings or measurement may require different reviewers. Keep a record of what changed and why, especially when the change affects the information collected or the expectation set by the ad.
If the practice cannot handle the resulting inquiries, assess capacity and message accuracy before increasing spend. If the platform rejects an ad, investigate the actual reason rather than trying to disguise the service or bypass the review. A disciplined process protects the integrity of the campaign and makes the scope easier for the practice to understand.
Prepare a practical handoff for the intake team
Give staff the approved ad and landing-page language so they know what a prospective client has been told. The intake owner can then recognize a mismatch, such as someone expecting immediate booking when the page promises only a reviewed request. Provide a clear route for correcting that mismatch in the campaign.
Dappr can scope campaign planning, creative coordination and management around these approved boundaries. Bring current service descriptions, account access, capacity information and responsible reviewers. The handoff should identify tested actions, reporting definitions and open limitations. It should not promise recovery, platform approval, a fixed appointment volume or an unverified privacy status.
Questions before you begin
Can a therapy campaign use ordinary remarketing lists?
Do not assume so. Google applies restrictions to advertiser-curated audiences for sensitive interest categories including health. Review the actual offer, campaign and audience settings before proposing a targeting method.
Can ads guarantee recovery or clinical results?
No. Use accurate, clinician-approved service descriptions and a truthful next step. Advertising activity and website inquiries cannot establish or guarantee an individual treatment outcome.
What should a landing-page form collect?
Only the information approved for that specific first-contact process. Detailed clinical history should not be solicited through an unreviewed advertising form. Routing, access and measurement also need review.
Is a platform-approved ad automatically appropriate for the practice?
No. Platform acceptance is separate from clinical accuracy, professional obligations and the suitability of data handling. Each relevant reviewer should assess the actual arrangement before activation.
How should results be reported?
Separate clicks, approved contact actions and later operational outcomes where reliable evidence exists. Preserve unknowns and avoid sharing clinical details in marketing reports. Do not present ad metrics as proof of therapeutic benefit.